Raloxifene HCl – Naringin co-amorphous system: Preparation, characterization and pharmacokinetic studies
European Journal of Pharmaceutics and Biopharmaceutics · 2025
DOI: 10.1016/j.ejpb.2025.114667 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Navya Sree Kola Srinivas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 5…. Hauptthemen laut MEDLINE: Raloxifene Hydrochloride, Flavanones. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manipal Academy of Higher Education - Manipal Campus.
Abstract (Originalsprache)
Approximately 90 % of NCEs in development and 40 % of recently approved drugs are poorly water-soluble. To improve solubility and stability, co-amorphous systems (CAMs) are used, involving the amorphization of an API with a co-former through interactions like hydrogen bonding. This study explores the co-amorphization of Raloxifene HCl (RLX) and Naringin (NRG). RLX, a BCS class II drug, has limited oral bioavailability of only 2 % due to its poor solubility (0.5 μg/mL) and extensive pre-systemic metabolism. Additionally, it interacts with CYP3A4 and P-glycoprotein (P-gp). NRG, a compound found in citrus fruits, inhibits both CYP3A4 and P-gp. Therefore, utilizing NRG to prepare RLX CAMs could result in a compound with improved solubility and enhanced bioavailability. CAMs were prepared using the solvent evaporation technique, followed by solid-state characterization at the molecular level. Solubility, drug release, and both ex vivo and in vitro studies were conducted. CAMs showed a 3.5-fold solubility increase and a 10-fold increase in ex-vivo permeation compared to RLX. In vivo studies showed an 8.1-fold improvement in Cmax and a 2.8-fold increase in AUC, indicating significantly enhanced bioavailability. These results suggest that co-amorphization could be a viable platform technology for improving API properties at the molecular level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
- Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education & Research (NIPER) Guwahati, Assam 781101, India.
- Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India. Electronic address: km.bhat@manipal.edu.
Förderung
- Manipal Academy of Higher Education - Manipal Campus
Zitieren
APA
Kola Srinivas, N. S., Yarlagadda, D. L., Bheemishetty, B., Lewis, S., Dengale, S. J., & Bhat, K. (2025). Raloxifene HCl – Naringin co-amorphous system: Preparation, characterization and pharmacokinetic studies. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114667
Vancouver
Kola Srinivas NS, Yarlagadda DL, Bheemishetty B, Lewis S, Dengale SJ, Bhat K. Raloxifene HCl – Naringin co-amorphous system: Preparation, characterization and pharmacokinetic studies. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114667
BibTeX
@article{KolaSrinivas2025,
author = {Kola Srinivas, Navya Sree and Yarlagadda, Dani Lakshman and Bheemishetty, Brahmam and Lewis, Shaila and Dengale, Swapnil Jayant and Bhat, Krishnamurthy},
title = {Raloxifene HCl – Naringin co-amorphous system: Preparation, characterization and pharmacokinetic studies},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2025},
doi = {10.1016/j.ejpb.2025.114667}
}
EUVIMED